Testing brenipatide for alcohol use disorder
Treatments studied
Part of Mental health clinical trials.
This study tests an experimental medicine called brenipatide to help people reduce or stop drinking. It involves getting a daily injection and completing check-ins and questionnaires over several months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 20 years old (or meet age rules for your country).
- Want to stop or cut down on drinking and be ready to work on it.
- Be willing to give yourself daily injections (or have someone trained to help).
- Keep study diaries and answer questionnaires during the trial.
- Not have a serious drug problem (other than alcohol, nicotine, or caffeine) in the past 6 months.
- Not have had suicidal thoughts or behaviors in the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an injectable medicine called brenipatide to help people with moderate-to-severe alcohol use disorder reduce or stop drinking. It is for adults who are motivated to change their drinking habits.
This study tests whether brexpiprazole can help adults with alcohol use disorder. You must currently not be taking alcohol-focused treatment or alcohol medicines, and you’ll likely complete questionnaires and brain scans.
This Phase 2 study tests a brief medication approach meant to reduce “problem drinking.” It may help people cut back or stop alcohol use by adjusting brain signaling related to drinking cravings and urges.
This study tests whether a medication called tirzepatide (a once-weekly injection) can help people reduce their alcohol consumption. It is for people who drink heavily, have a high BMI, and are actively seeking help to drink less.
This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.
This trial tests two medicines — semaglutide and naltrexone — taken together to help reduce alcohol cravings and drinking. It aims to see if this combination is more effective than standard treatment for alcohol use disorder.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.